Myo vs. Myofascial Injection for Myofascial Trigger Points

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-26

Study Completion Date

2024-07-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the effectiveness of two different application methods that can be used in myofascial trigger point injection treatment will be compared.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Lidocaine, Mepivacaine, and Dry Needling in Myofascial Pain Syndrome

NCT07079449

Myofascial Pain Syndrome Temporomandibular Joint Disorders Facial Pain

COMPLETED NA

Manual Therapy Treatment for Myofascial Pain

NCT01381380

Myofascial Pain Syndromes

COMPLETED NA

Comparison of Vibration and Dry Needle in Trigger Point Therapy

NCT04900857

Myofascial Pain Syndrome Trigger Point Pain, Myofascial

COMPLETED NA

Comparison of Kinesio Taping, Dry Needling and Lidocain Injection Methods in Myofascial Pain Syndrome

NCT06018675

Myofascial Pain Syndrome

COMPLETED

Trigger Point Injection in Patients With Myofascial Pain Syndrome

NCT06555523

Injection Site Fibromyalgia

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to compare the intramuscular trigger point injection, which is traditionally used in the treatment of myofascial trigger points with the method in which facial layers are also included in the application.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myofascial Pain Myofascial Trigger Point Pain Trigger Point Pain, Myofascial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study is planned to compare the effects of USG guided intramuscular trigger point injection with the effects of USG guided intramuscular plus fascial trigger point injection. This is a single-center randomized trial with 2 parallel arms.

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Research arm

After the myofascial trigger points are determined by ultrasonography (HI VISION Preirus; Hitachi Aloka Medical, Ltd., Tokyo, Japan), injections will be given to the myofascial layers from the deep to the superficial. First, the local anesthetic solution will be injected to create a separation in the intermuscle (epimysial) fascia. The injectable will then be infiltrated into the intermuscular hypoechoic nodule. Then, the deep fascia will be infiltrated layer by layer. Finally, the procedure will be completed by infiltrating the superficial fascia.

Group Type EXPERIMENTAL

myo + fascial injection

Intervention Type PROCEDURE

10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as well as for fascial layers as described.

Control arm

Patients in the control group will be injected with the same amount of local anesthetic solution under ultrasound guidance to intramuscular hypoechoic nodules detected by ultrasonography (HI VISION Preirus; Hitachi Aloka Medical, Ltd., Tokyo, Japan).

Group Type ACTIVE_COMPARATOR

traditional trigger point injection

Intervention Type PROCEDURE

10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as described.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

myo + fascial injection

10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as well as for fascial layers as described.

Intervention Type PROCEDURE

traditional trigger point injection

10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as described.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Pain in the upper back area

Detection of active trigger point in upper back muscles (trapezius, levator scapula, rhomboids, supraspinatus and infraspinatus)

Presence of at least two of the three criteria recommended for the diagnosis of trigger point:

1. Taut band
2. Hypersensitive point
3. Referred pain

Pain VAS score ≥ 4

Between the ages of 18-65 -

Exclusion Criteria

Using analgesics or anti-inflammatory medicines.

Having received physical therapy for the same symptoms in the past 3 months

Serious psychiatric illness

Presence of malignancy or infection

Coagulation disorder

Pregnancy

History of operation in the relevant region

Presence of fibromyalgia syndrome

History of allergy to local anesthetics

\-

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No